.avif)
Parallel Bio has reimagined drug discovery by creating a “map of human biology” — a population-scale, perturbable, fully human biological atlas built on patient samples and computational tools. The company reports testing 50+ compounds with 87% concordance with human outcomes, operating 10x faster and at 1000x lower costs than traditional drug discovery, with zero animal use. They are working with multiple companies including three Fortune 500 partners, and have informed at least one Phase 1 trial with their data.
.svg)
